Xtant Medical Holdings (XTNT) Depreciation & Amortization (IS) (2010 - 2019)

Xtant Medical Holdings (XTNT) has 10 years of Depreciation & Amortization (IS) data on file, last reported at $137000.0 in Q3 2019.

• Depreciation & Amortization (IS) for Q3 2019 came in at $137000.0, down 86.69% year-over-year; the trailing twelve-month figure through Sep 2019 was $1.5 million (down 66.64% YoY), and the FY2018 annual result was $4.1 million, down 24.92% from the prior year.
• Depreciation & Amortization (IS) fell to $137000.0 in Q3 2019 per XTNT's latest filing, from $146000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (IS) peaked at $2.1 million in Q4 2015 and troughed at $100663.0 in Q2 2015.
• A 5-year average of $989765.5 and a median of $1.2 million in 2016 frame the typical range for Depreciation & Amortization (IS).
• The sharpest annual moves came in 2015 and 2019: Depreciation & Amortization (IS) soared 3606.51% in 2015, then plunged 86.69% in 2019.
• A 5-year view of Depreciation & Amortization (IS) shows it stood at $2.1 million in 2015, then slumped by 39.11% to $1.3 million in 2016, then advanced by 10.36% to $1.4 million in 2017, then declined by 24.35% to $1.0 million in 2018, then plunged by 86.88% to $137000.0 in 2019.
• Business Quant data shows XTNT's Depreciation & Amortization (IS) at $137000.0 in Q3 2019, $146000.0 in Q2 2019, and $159000.0 in Q1 2019.